Clinical Significance of a Novel Tumor Progression-Associated Immune Signature in Colorectal Adenocarcinoma

BACKGROUND: Some colorectal adenocarcinoma (CRC) patients are susceptible to recurrence, and they rapidly progress to advanced cancer stages and have a poor prognosis. There is an urgent need for efficient screening criteria to identify patients who tend to relapse in order to treat them earlier and...

Descripción completa

Detalles Bibliográficos
Autores principales: Mao, Rui, Yang, Fan, Wang, Zheng, Xu, Chenxin, Liu, Qian, Liu, Yanjun, Zhang, Tongtong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7959763/
https://www.ncbi.nlm.nih.gov/pubmed/33732694
http://dx.doi.org/10.3389/fcell.2021.625212

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7959763/
https://www.ncbi.nlm.nih.gov/pubmed/33732694
http://dx.doi.org/10.3389/fcell.2021.625212

Ejemplares similares